Direxion Daily Semiconductor Bull 3x Shares ETF
SOXL
United States Natural Gas
UNG
Invesco Solar ETF
TAN
4
The Technology Select Sector SPDR® Fund
XLK
5
The Health Care Select Sector SPDR® Fund
XLV
US Stock MarketDetailed Quotes
Nautilus Biotechnology (NAUT)
- 2.390
- -0.290-10.82%
Close Jun 5 16:00 ET
- 2.450
- +0.060+2.51%
Post 16:16 ET
303.72MMarket Cap-5.20P/E (TTM)
2.670High2.365Low491.12KVolume2.650Open2.680Prev Close1.21MTurnover1.04%Turnover RatioLossP/E (Static)127.08MShares4.31052wk High2.10P/B112.85MFloat Cap0.62052wk Low--Dividend TTM47.22MShs Float25.886Historical High--Div Yield TTM11.38%Range %0.620Historical Low2.469Avg Price1Lot Size
NAUT Stock Chart
After-Hours
- 5D
- Daily
- Weekly
- Monthly
- 1Q
- 1Y
NAUT Orderflow
Unit: --
NAUT Orderflow Trend
IntradayDayWeekMonth
No Data
Nautilus Biotechnology (NAUT) News
Major Nautilus Biotechnolgy Investor Quietly Unloads a Massive Stake
Nautilus Data Technologies' Facility Cooling Distribution Unit Exceeds Performance Benchmarks for Next-Generation AI GPU Workloads
Nautilus Biotechnology Decline Means Insider Profits Down To US$432k
Most and Least Shorted Small-to-mid-cap Stocks
Most and Least Shorted Healthcare Stocks With up to $2B Market Cap in May
Guggenheim Maintains Nautilus Biotechnology(NAUT.US) With Buy Rating, Maintains Target Price $4
Nautilus Biotechnology (NAUT) Stock Forum
two codes to jump on or watch going into 2026.
Nautilus has proven strong in 2025.
Datavault looks well supported.
both at fair, if not discounted prices. I look forward to watching their progress.
$Datavault AI (DVLT.US)$
$Nautilus Biotechnology (NAUT.US)$
Nautilus has proven strong in 2025.
Datavault looks well supported.
both at fair, if not discounted prices. I look forward to watching their progress.
$Datavault AI (DVLT.US)$
$Nautilus Biotechnology (NAUT.US)$
5
2
1
$Nautilus Biotechnology (NAUT.US)$ Nautilus Biotechnology Q3 EPS $(0.11) Beats $(0.15) Estimate. Cash And Equivalents Of $168.5M
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year.
Nautilus Biotechnology (NASDAQ:NAUT) reported quarterly losses of $(0.11) per share which beat the analyst consensus estimate of $(0.15) by 26.67 percent. This is a 15.38 percent increase over losses of $(0.13) per share from the same period last year.
2
$Nautilus Biotechnology (NAUT.US)$
i dont know when but i just know there is
i dont know when but i just know there is
3
Read more
Market Insights
Hot Topics Hot Topics
Surf the ETF wave: Master the market with wisdom & ease!
As the financial landscape evolves, ETFs have emerged as a versatile tool for investors seeking to grow wealth, diversify portfolios, and st
102362254
Sep 4, 2024 16:25
Sharing my long-term ETF story
mr_cashcow
Sep 11, 2024 10:30
Low cost ETF is the way to go! September P/L challenge #6 (200words count entry)
Annoynimous : yoooo that's a strong 3 month rally on Nautilus, too afraid to try today though everyone's getting whacked
simplisticscott OP Annoynimous : buy the dip, at this point any investment between here and eofy would be a good investment in my opinion. that's just what I'm seeing from them so far.